microRNA Name | Fold Change | Type | Numerator (r) | Denominator (s+s0) | Correlation with cancer |
---|---|---|---|---|---|
squamous cell carcinoma vs normal cheek pouch tissue | |||||
hsa-miR-21 | 2.590 | up | 2.495 | 1.371 | Up-regulated in glioblastomas[11], breast[8], colon[7], lung[9], pancreatic[17], thyroid[10], and ovarian cancer[15] |
hsa-miR-200b | 2.192 | up | 1.645 | 0.964 | Up-regulated in ovarian cancer[15] |
hsa-miR-221 | 2.018 | up | 1.561 | 0.988 | Up-regulated in CLL[8], glioblastomas[11], thyroid[10], and pancreatic cancer[17] |
hsa-miR-338 | 2.436 | up | 1.323 | 0.493 | Â |
mmu-miR-762 | 2.379 | up | 1.863 | 1.052 | Â |
hsa-miR-16 | 0.182 | down | -2.501 | 0.458 | |
hsa-miR-26a | 0.135 | down | -2.288 | 1.148 | |
hsa-miR-29a | 0.245 | down | -1.532 | 0.785 | Down-regulated in ovarian cancer[15] |
hsa-miR-124a | 0.216 | down | -1.819 | 0.702 | |
hsa-miR-125b | 0.414 | down | -1.282 | 0.418 | Down-regulated in breast[8], lung[9], ovarian[15], cervical[16], and prostate cancer[12] |
mmu-miR-126-5p | 0.424 | down | -1.117 | 0.536 | Â |
hsa-miR-143 | 0.393 | down | -1.245 | 0.605 | Down-regulated in prostate[12], Lung[9], breast[8], hepatocellular[14], colon[7], cervical[16], and ovarian cancer[15] |
hsa-miR-145 | 0.317 | down | -2.130 | 0.899 | Down-regulated in prostate[12], Lung[9], breast[8], hepatocellular[14], ovarian[15], cervical[16], and colon cancer[7] |
hsa-miR-148b | 0.317 | down | -2.130 | 0.899 | |
hsa-miR-155 | 0.376 | down | -1.374 | 0.486 | Up-regulated in CLL[8], thyroid[10], lymphomas[13], lung[9], breast cancer[8] Down-regulated in pancreatic cancer[17] |
hsa-miR-199a | 0.261 | down | -1.411 | 0.847 | Down-regulated in prostate[12], and hepatocellular cancer[14] |
hsa-miR-203 | 0.175 | down | -1.925 | 0.910 | Down-regulated in colon[7], and breast cancer[8] Up-regulated in ovarian cancer[15] |